Keywords: alizyme, updates, ph, iii, program, preparation, busy

Alizyme updates on Ph III R&D program in preparation for a busy 2008

Article | 22 October 2007

Print This

Since completing a round of management changes late last year, which included the appointment of Tim McCarthy as chief executive ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in